Susceptibility to fluconazole and amphotericin B in clinical Candida isolates;Sensibilidad al fluconazol y a la anfotericina B en cepas de Candida provenientes de aislamientos clinicos

Revista Iberoamericana de Micologia

Volumn 15, Issue 4, 1998, Pages 298-299

  Martínez, Javier ^a,b   Albrecht, Cristina ^a  

^a Hospital Nacional de Clinicas   (Argentina)

^b Ciuctad de Justo Daract ^*  (Argentina)

Author keywords

Amphotericin B; Candida; Fluconazole; Susceptibility

Indexed keywords

EID: 0000820445     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Phillips G, Golledge C Fungal infections in neonates. J Antimicrob Chemother 1991; 28:159-61.
2. Leibovitz E, Rigaud M, Chanduvani S, et al Disseminated fungal infections in children infected with human inmunodeficiency virus. Pedtatr Infect Dis 1991;10:888-894.
3. Georgopapadakou NH, Walsh TJ. Antifungal agents: Chemotherapeutic targets and inmunologic strategies. Antimicrob Agents Chemother 1996;40: 279-291.
4. Fan Havard P, Capano D, Smith SM, Mangoa A, Eng RHK. Development of resistance in Candida isolates fron patients receiving prolonged antifugal therapy. Antimicrob Agents Chemoter 1991; 35: 2302-2305.
5. De Muri et al Resistance to antifungal agents. Pediatr Clin North Am 1995; 42: 665-85.
6. NCCLS National Committe for Clinical Laboratory Standard Reference Method for broth dilution antifungal susceptibility testing for yeast. Proposed standart Document M27 P Villanova, PA, 1992.
7. NCCLS National Committe for Clinical Laboratory Standard Reference Method for broth dilution antifungal susceptibility testing for yeast. Approved standart Document M27-A. Villanova, PA. 1997.
8. Campbell BA, Steward BS, Larsh Howard (Eds ). The Medical Mycology Handbook. 1980.
9. Murray PR, et al Manual of clinical microbiology ASM Press 1980.
10. Pfaller MA, Barry AL. In vitro susceptibility of clinical yeast isolates to three antifungal agents determined by the microdilution method. Mycopathologia 1995; 130:3-9.
11. Preston S, Briceland L. Fluconazole for antifungal prophilaxis in chemotherapy induced neutropema. Am J Health Syst Pharm 1995, 52.
12. Roderp L, Boutureira M, Vitale R, et al. Infecciones por levaduras; agentes causales y su resistencia a antifúngicos en pacientes pediatricos hospitalizados y en adultos HIV positivos. Rev Arg Microbiol 1997;29:7-15.
13. Warnock DW, Burke J, Cope NJ, Johnson EM, Von Fraunnofer NA. Fluconazol resistance in Candida glabrata. Lancet 1998;11:1310.